HURA
Price
$2.60
Change
+$0.01 (+0.39%)
Updated
Sep 3 closing price
Capitalization
129.12M
INAB
Price
$2.21
Change
-$0.00 (-0.00%)
Updated
Sep 3 closing price
Capitalization
10.06M
Interact to see
Advertisement

HURA vs INAB

Header iconHURA vs INAB Comparison
Open Charts HURA vs INABBanner chart's image
TuHURA Biosciences
Price$2.60
Change+$0.01 (+0.39%)
Volume$153.49K
Capitalization129.12M
IN8bio
Price$2.21
Change-$0.00 (-0.00%)
Volume$21.59K
Capitalization10.06M
HURA vs INAB Comparison Chart in %
Loading...
HURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HURA vs. INAB commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HURA is a Hold and INAB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (HURA: $2.60 vs. INAB: $2.21)
Brand notoriety: HURA and INAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HURA: 32% vs. INAB: 20%
Market capitalization -- HURA: $129.12M vs. INAB: $10.06M
HURA [@Biotechnology] is valued at $129.12M. INAB’s [@Biotechnology] market capitalization is $10.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HURA’s FA Score shows that 0 FA rating(s) are green whileINAB’s FA Score has 1 green FA rating(s).

  • HURA’s FA Score: 0 green, 5 red.
  • INAB’s FA Score: 1 green, 4 red.
According to our system of comparison, HURA is a better buy in the long-term than INAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HURA’s TA Score shows that 4 TA indicator(s) are bullish while INAB’s TA Score has 2 bullish TA indicator(s).

  • HURA’s TA Score: 4 bullish, 5 bearish.
  • INAB’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, HURA is a better buy in the short-term than INAB.

Price Growth

HURA (@Biotechnology) experienced а -10.34% price change this week, while INAB (@Biotechnology) price change was -2.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HURA($129M) has a higher market cap than INAB($10.1M). HURA YTD gains are higher at: -36.430 vs. INAB (-71.293). INAB has higher annual earnings (EBITDA): -20.28M vs. HURA (-25.16M). INAB has more cash in the bank: 13.2M vs. HURA (8.51M). HURA has less debt than INAB: HURA (559K) vs INAB (3.12M). HURA (0) and INAB (0) have equivalent revenues.
HURAINABHURA / INAB
Capitalization129M10.1M1,277%
EBITDA-25.16M-20.28M124%
Gain YTD-36.430-71.29351%
P/E RatioN/AN/A-
Revenue00-
Total Cash8.51M13.2M64%
Total Debt559K3.12M18%
FUNDAMENTALS RATINGS
HURA: Fundamental Ratings
HURA
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HURAINAB
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 18 days ago
84%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
HURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VSTTF0.070.01
+16.67%
Vast Renewables Limited
VMNT0.280.01
+1.97%
Vemanti Group Inc.
JMHLY60.180.68
+1.14%
Jardine Matheson Holdings Ltd.
GRPOF0.81N/A
N/A
GRUPO TRAXION S A B DE C V
BYDGF161.53-1.15
-0.71%
BOYD GROUP SVCS INC.

HURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HURA has been loosely correlated with GNPX. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if HURA jumps, then GNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HURA
1D Price
Change %
HURA100%
+0.39%
GNPX - HURA
60%
Loosely correlated
+3.73%
ETHZ - HURA
56%
Loosely correlated
-5.62%
SNSE - HURA
48%
Loosely correlated
+10.57%
BIVI - HURA
45%
Loosely correlated
+5.70%
CMND - HURA
37%
Loosely correlated
-2.88%
More

INAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, INAB has been loosely correlated with IDYA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if INAB jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INAB
1D Price
Change %
INAB100%
+0.23%
IDYA - INAB
47%
Loosely correlated
+1.10%
SRZN - INAB
39%
Loosely correlated
+1.79%
GRI - INAB
37%
Loosely correlated
+4.29%
SNSE - INAB
37%
Loosely correlated
+10.57%
HURA - INAB
36%
Loosely correlated
+0.39%
More